Vascular complications account for the greatest numbers of deaths in diabetic patients. However, the molecular mechanisms responsible for these complications remain poorly understood. We recently reported that the expression of thrombospondin-1 (TSP-1) is strikingly elevated in large vessels of Zucker rats, an animal model of type 2 diabetes, both in basal conditions and in response to injury, suggesting a role for this protein in the accelerated atherosclerosis and increased restenosis in this animal model and diabetic patients. TSP-1 has a number of well-documented proatherogenic properties, including genetic and biochemical evidence, and is also one of the most potent antiangiogenic agents, a function directly relevant to diabetic complications. Our preliminary data indicated that TSP-1 expression is regulated by glucose at the transcriptional level and suggested possible signaling pathways for this activation. We will test the hypothesis that specific signaling and transcriptional molecular mechanisms rapidly activated by acute stimulation of arterial smooth muscle cells (SMC) with high glucose mediate the increased expression of TSP-1 in the wall of large blood vessels and provide a link between hyperglycemia and accelerated atherogenesis. The overall goal of the proposed project is to elucidate specific signaling and transcriptional mechanisms responsible for the upregulation of TSP-1 expression by glucose in SMC and to test whether that increased expression of TSP-1 in the vascular wall contributes to the development of atherosclerotic lesions. The long-term objective is to uncover the hyperglycemia-induced molecular mechanisms that lead to development of vascular complications.
Specific Aims are: 1. To identify the promoter region of the TSP-1 gene and nuclear factors responsible for the upregulation of TSP-1 by glucose;2. To identify signaling pathways involved in regulation of TSP-1 expression by glucose;3. To demonstrate directly in the transgenic mouse model that increased expression of TSP-1 in the vascular wall contributes to the development of atherosclerotic lesions. The results of these experiments will: 1) identify targets for the regulation of TSP-1, a potent antiangiogenic and proatherogenic protein that may contribute to vascular diabetic complications;2) provide additional information about the molecular mechanisms of the effects of glucose in SMC;and 3) demonstrate directly that TSP-1 may serve as a link between diabetes and vascular complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK067532-05
Application #
7860426
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Jones, Teresa L Z
Project Start
2006-08-15
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
5
Fiscal Year
2010
Total Cost
$269,264
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Muppala, Santoshi; Frolova, Ella; Xiao, Roy et al. (2015) Proangiogenic Properties of Thrombospondin-4. Arterioscler Thromb Vasc Biol 35:1975-86
Duncan, Andra E; Kateby Kashy, Babak; Sarwar, Sheryar et al. (2015) Hyperinsulinemic Normoglycemia Does Not Meaningfully Improve Myocardial Performance during Cardiac Surgery: A Randomized Trial. Anesthesiology 123:272-87
Krukovets, Irene; Legerski, Matthew; Sul, Pavel et al. (2015) Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist. FASEB J 29:3726-36
Stenina-Adognravi, Olga (2014) Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol 37:69-82
Frolova, Ella G; Drazba, Judith; Krukovets, Irene et al. (2014) Control of organization and function of muscle and tendon by thrombospondin-4. Matrix Biol 37:35-48
Stenina-Adognravi, Olga (2013) Thrombospondins: old players, new games. Curr Opin Lipidol 24:401-9
Bhattacharyya, Sanghamitra; Sul, Kristina; Krukovets, Irene et al. (2012) Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia. J Am Heart Assoc 1:e005967
Raman, Priya; Harry, Christy; Weber, Malory et al. (2011) A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose. Arterioscler Thromb Vasc Biol 31:634-42
Frolova, Ella G; Pluskota, Elzbieta; Krukovets, Irene et al. (2010) Thrombospondin-4 regulates vascular inflammation and atherogenesis. Circ Res 107:1313-25
Dabir, Pankaj; Marinic, Tina E; Krukovets, Irene et al. (2008) Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circ Res 102:1558-65

Showing the most recent 10 out of 14 publications